Abbonarsi

A novel intramural TGF β 1 hydrogel delivery method to decrease murine abdominal aortic aneurysm and rat aortic pseudoaneurysm formation and progression - 19/03/21

Doi : 10.1016/j.biopha.2021.111296 
Hualong Bai a, c, , Peng Sun a, Shunbo Wei a, Boao Xie a, Mingxing Li a, Yanhua Xu d, Wang Wang b, c, Yuanfeng Liu a, Liwei Zhang a, Haoliang Wu a, Zhiju Wang b, c, Ying Xing b, c, Zhiwei Wang a, , Jing’an Li e,
a Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, China 
b Department of Physiology, Medical School of Zhengzhou University, Henan, China 
c Key Vascular Physiology and Applied Research Laboratory of Zhengzhou City, Henan, China 
d Department of Internal Medicine, First Affiliated Hospital of Zhengzhou University, Henan, China 
e School of Material Science and Engineering & Henan Key Laboratory of Advanced Magnesium Alloy & Key Laboratory of Materials Processing and Mould Technology (Ministry of Education), Zhengzhou University, Henan, China 

Corresponding authors at: Department of Vascular and Endovascular Surgery, First Affiliated Hospital of Zhengzhou University, Henan, 450052, China.Department of Vascular and Endovascular SurgeryFirst Affiliated Hospital of Zhengzhou UniversityHenan450052China⁎⁎Corresponding author at: School of Material Science and Engineering, Zhengzhou University, Henan, 450001, China.School of Material Science and EngineeringZhengzhou UniversityHenan450001China

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

pagine 8
Iconografia 6
Video 0
Altro 0

Highlights

Intramural delivery of TGF β 1 hydrogel is a novel drug delivery system that can decease aneurysm and pseudoaneurysm formation and progression.
This method can secure the drug in place between the medium and adventitia in the aneurysm and pseudoaneurysm and release slowly.
This method may have a potential clinical translational application.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Objectives

Aneurysms are generally the result of dilation of all 3 layers of the vessel wall, and pseudoaneurysms are the result of localized extravasation of blood that is contained by surrounding tissue. Since there is still no recommended protocol to decrease aneurysm formation and progression, we hypothesised that intramural delivery of TGF β1 hydrogel can decrease aneurysm and pseudoaneurysm formation and progression.

Materials

Male C57BL/6 J mice (12–14 wk), SD rats (200 g) and pig abdominal aortas were used, and hydrogels were fabricated by the interaction of sodium alginate (SA), hyaluronic acid (HA) and CaCO3.

Methods

A CaCl2 adventitial incubation model in mice and a decellularized human great saphenous vein patch angioplasty model in rats were used. TGF β1 hydrogel was intramurally delivered after CaCl2 incubation in mice; at day 7, the abdomen in some mice was reopened, and TGF β1 hydrogel was injected intramurally into the aorta. In rats, TGF β1 hydrogel was delivered intramurally after patch angioplasty completion. Tissues were harvested at day 14 and analysed by histology and immunohistochemistry staining. The pig aorta was also intramurally injected with hydrogel.

Results

In mice, rhodamine hydrogel was still found between the medium and adventitia at day 14. In the mouse aneurysm model, there was a thicker wall and smaller amount of elastin breaks in the TGF β1 hydrogel-delivered groups both at day 0 and day 7 after CaCl2 incubation, and there were larger numbers of p-smad2- and TAK1-positive cells in the TGF β1 hydrogel-injected groups. In the rat decellularized human saphenous vein patch pseudoaneurysm model, there was a higher incidence of pseudoaneurysm formation when the patch was decellularized using 3% SDS, and delivery of TGF β1 hydrogel could effectively decrease the formation of pseudoaneurysm formation and increase p-smad2 and TAK1 expression. In pig aortas, hydrogels can be delivered between the medium and adventitia easily and successfully.

Conclusions

Intramural delivery of TGF β1 hydrogel can effectively decease aneurysm and pseudoaneurysm formation and progression in both mice and rats, and pig aortas can also be successfully intramurally injected with hydrogel. This technique may be a promising drug delivery method and therapeutic choice to decrease aneurysm and pseudoaneurysm formation and progression in the clinic.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : DAB, H&E, HRP, SD, TGF, EVG

Keywords : Intramural delivery, TGF β 1, Aneurysm, Pseudoaneurysm, Hydrogel


Mappa


© 2021  The Author(s). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 137

Articolo 111296- maggio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • An in vivo explorative study to observe the protective effects of Puerariae flos extract on chronic ethanol exposure and withdrawal male mice
  • Bo Jiang, Wenhui Yang, Zhilong Xiu, Liuwei Zhang, Xinxiu Ren, Lijun Wang, Lei Chen, Tetsuya Asakawa
| Articolo seguente Articolo seguente
  • ShRNA-mediated silencing of PD-1 augments the efficacy of chimeric antigen receptor T cells on subcutaneous prostate and leukemia xenograft
  • Jing-e Zhou, Jing Yu, Yeying Wang, Hao Wang, Jing Wang, Yiting Wang, Lei Yu, Zhiqiang Yan

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.